Toronto Dominion Bank
BVS icon

Toronto Dominion Bank’s Bioventus BVS Stock Holding History

Toronto Dominion Bank’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-16,666
Closed -$175K – 1555
2024
Q4 		$175K Buy
+16,666
New +$197K ﹤0.01% 1286

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
JIC
Juniper Investment Company New York $313M AUM 79.58% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Toronto Dominion Bank's BVS Position: Q1 2025 in Review

Toronto Dominion Bank sold out of Bioventus (BVS) in Q1 2025, closing a stake of 16,666 shares — an estimated $175K sold.

Toronto Dominion Bank first reported a position in BVS in Q4 2024 and held it in 1 quarter. The position peaked at $175K in Q4 2024. 144 funds tracked by Wall St. Rank hold BVS as of Q1 2025.

  • Toronto Dominion Bank reported no remaining Bioventus position as of Q1 2025 after selling out during the quarter.
  • Toronto Dominion Bank sold 16,666 Bioventus shares in Q1 2025, an estimated $175K.
  • Toronto Dominion Bank first reported a position in Bioventus in Q4 2024 and held it in 1 quarter.
  • Toronto Dominion Bank's Bioventus position peaked at $175K in Q4 2024.
  • 144 funds tracked by Wall St. Rank held Bioventus as of Q1 2025.

Based on Toronto Dominion Bank's 13F filing for Q1 2025, filed 15 May 2025.